Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference
January 05 2021 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that management is scheduled to
participate in a fireside chat at the virtual H.C. Wainwright
BioConnect 2021 Conference to be held January 11-14, 2021.
The fireside chat will be available on-demand through the H.C.
Wainwright conference portal, starting at 6 a.m. EST on Monday,
January 11, 2021. An archived webcast will also be accessible
through the Events page of the company's website
(www.otonomy.com).
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs including Ménière’s disease, hearing loss, and
tinnitus. For additional information, please visit
www.otonomy.com.
Contacts:
Media InquiriesSpectrum ScienceChloé-Anne RamseyVice
President404.865.3601cramsey@spectrumscience.com
Investor InquiriesWestwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From May 2024 to Jun 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2023 to Jun 2024